Updates to GitHub Copilot in VS Code provide the same C++ symbol context and CMake build configuration awareness as Microsoft’s C/C++ DevTools and CMake Tools extensions.

Visual Studio Code 1.109 introduces enhancements for providing agents with more skills and context and managing multiple agent sessions in parallel. Microsoft has released Visual Studio Code 1.109, ...

Multi-agent orchestration makes workflow more inspectable, with clear handoffs and a QA backstop. Breaking the work into discrete steps makes the output easier to audit and fix. A timestamped handoff ...

Vulnerabilities with high to critical severity ratings affecting popular Visual Studio Code (VSCode) extensions collectively downloaded more than 128 million times could be exploited to steal local ...

Visual Studio Code 1.109 introduces structured, multi-agent workflows that move AI assistance beyond single-chat interactions. Parallel subagents enable concurrent task execution without consuming the ...

Does Excel Power Query keep crashing with Error 0xC000026F? It occurs due to compatibility issues between Power Query engine and ARM-based processors ...

Microsoft-owned GitHub continues to embrace OpenAI and Anthropic AI advances. Microsoft-owned GitHub continues to embrace OpenAI and Anthropic AI advances. is a senior editor and author of Notepad, ...

Ring Team Announces Significant New Contributions by Developer Youssef Saeed Youssef’s contributions, creativity, and ...

TIOBE Index for February 2026: Top 10 Most Popular Programming Languages Your email has been sent February’s TIOBE Index shows a leaderboard that looks steady at first glance, but small shifts beneath ...

Speaking of Leguizamo, as an actor, Schofield moves effortlessly through humor, absurdity, grief, tenderness, and philosophical reflection, but the delivery remains grounded. His charm is indelible ...

Listening to the news can feel like a journey. But 1A guides you beyond the headlines – and cuts through the noise. Let's get to the heart of the story, together – on 1A.

Phase 1b Trial Reported Approximately 65% Pathological Response in cSCC, Including Complete Responses at Maximum Dose, ...